(Total Views: 113)
Posted On: 05/20/2022 11:25:50 AM
Post# of 36300

$LLY News Article - CHMP Recommends Approval of Lilly and Incyte's OLUMIANT (baricitinib) as the First and Only Centrally-Authorized Treatment for Adults with Severe Alopecia Areata (AA) https://marketwirenews.com/news-releases/chmp...45780.html


My Twitter: WhyteStocks